COMPOSITIONS AND METHODS FOR CONTROLLING ABUSE OF MEDICATIONS
First Claim
Patent Images
1. A pharmaceutical dosage form comprising:
- a first plurality of microcapsules, each microcapsule of the first plurality containing an opioid agonist medication in a controlled release form; and
a second plurality of microcapsules, each microcapsule of the second plurality containing a partial opioid agonist, wherein the partial opioid agonist is provided in a sequestered form in the pharmaceutical dosage form, such that the partial opioid agonist is released in an effective amount in vivo if the pharmaceutical dosage form is administered to a person in an altered form but is not released in an effective amount in vivo if the pharmaceutical dosage form is administered to a person in a substantially unaltered form.
1 Assignment
0 Petitions
Accused Products
Abstract
Pharmaceutical dosage forms are provided for use in deterring abuse of opioids or other medications, which help avoid harm to a patient dependent on the medication. In one case, a pharmaceutical oral dosage form is provided that includes a plurality of microcapsules, each microcapsule of the plurality containing an opioid agonist medication in a controlled release form, and a partial opioid agonist sequestered in the pharmaceutical dosage form, such that upon oral administration of the pharmaceutical oral dosage form the partial opioid agonist will pass through the gastrointestinal tract without uptake by the body.
-
Citations
17 Claims
-
1. A pharmaceutical dosage form comprising:
-
a first plurality of microcapsules, each microcapsule of the first plurality containing an opioid agonist medication in a controlled release form; and
a second plurality of microcapsules, each microcapsule of the second plurality containing a partial opioid agonist, wherein the partial opioid agonist is provided in a sequestered form in the pharmaceutical dosage form, such that the partial opioid agonist is released in an effective amount in vivo if the pharmaceutical dosage form is administered to a person in an altered form but is not released in an effective amount in vivo if the pharmaceutical dosage form is administered to a person in a substantially unaltered form. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. A pharmaceutical oral dosage form comprising:
-
a plurality of microcapsules, each microcapsule of the plurality containing an opioid agonist medication in a controlled release form; and
a partial opioid agonist sequestered in the pharmaceutical dosage form, such that upon oral administration of the pharmaceutical oral dosage form the partial opioid agonist will pass through the gastrointestinal tract without uptake by the body. - View Dependent Claims (14, 15, 16)
-
-
17. A pharmaceutical oral dosage form comprising:
-
opioid agonist medication particles coated by or dispersed in a degradable matrix material which provides controlled release in vivo; and
partial opioid agonist coated by or dispersed in a non-degradable material.
-
Specification